Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(20%)
Results Posted
40%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
6
60%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
unknown2
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
83.3%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

unknown220%
active_not_recruiting220%
terminated110%
completed550%

Recent Activity

2 active trials
Showing 5 of 10
active_not_recruitingnot_applicable

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

NCT01538550
active_not_recruiting

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

NCT02389075
terminatednot_applicable

Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells

NCT02863029
completed

Biomarkers for Intestinal Permeability in Patients With Constipation

NCT02246647
completednot_applicable

Evaluation of Flexible Sigmoidoscopy Screening as an Adjunct to the National FOBT Screening Programme in Scotland

NCT02560194
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT01538550Not Applicable

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

Active Not Recruiting
NCT02389075

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

Active Not Recruiting
NCT02863029Not Applicable

Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells

Terminated
NCT02246647

Biomarkers for Intestinal Permeability in Patients With Constipation

Completed
NCT02560194Not Applicable

Evaluation of Flexible Sigmoidoscopy Screening as an Adjunct to the National FOBT Screening Programme in Scotland

Completed
NCT02465463Phase 1

Early FMT for C.Difficile

Completed
NCT02869152Not Applicable

Sentinel Lymph Node Mapping in Rectal Cancer

Unknown
NCT02630082Not Applicable

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

Completed
NCT00075062

A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials

Completed
NCT00253812Not Applicable

Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy

Unknown

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10